Capricor Therapeutics
CAPR
#7737
Rank
NZ$0.80 B
Marketcap
NZ$13.92
Share price
21.91%
Change (1 day)
23.54%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -NZ$0.2 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.18 Billion a decrease over its 2024 earnings that were of -NZ$67.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.2 Billion11.13%
2025 -NZ$0.18 Billion159.57%
2024 -NZ$67.95 Million81.57%
2023 -NZ$37.42 Million-23.2%
2022 -NZ$48.73 Million44.93%
2021 -NZ$33.62 Million46.61%
2020 -NZ$22.93 Million78.71%
2019 -NZ$12.83 Million-49.7%
2018 -NZ$25.51 Million-724.78%
2017 NZ$4.08 M-112.93%
2016 -NZ$31.58 Million46.27%
2015 -NZ$21.59 Million106.82%
2014 -NZ$10.44 Million-48.41%
2013 -NZ$20.24 Million977.23%
2012 -NZ$1.88 Million-77.11%
2011 -NZ$8.21 Million-22.35%
2010 -NZ$10.57 Million-20.17%
2009 -NZ$13.24 Million-41.17%
2008 -NZ$22.5 Million41.05%
2007 -NZ$15.96 Million1098.87%
2006 -NZ$1.34 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.61 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.34 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.4 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.52 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$10.48 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$25.05 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA